Invivyd Inc
General ticker "IVVD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $69.5M
Invivyd Inc does not follow the US Stock Market performance with the rate: -35.5%.
Estimated limits based on current volatility of 6.1%: low 0.41$, high 0.46$
Factors to consider:
- Current price 76.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [2.03$, 5.49$]
- 2024-12-30 to 2025-12-30 estimated range: [1.83$, 4.96$]
Financial Metrics affecting the IVVD estimates:
- Negative: Non-GAAP EPS, $ of -1.81 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -41.88 <= 2.35
- Negative: negative Net income
- Positive: Interest expense per share, $ of 0 <= 0
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
- Positive: Industry inventory ratio change (median), % of 0 <= 0
Short-term IVVD quotes
Long-term IVVD plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $226.91MM | $248.03MM | $207.78MM |
| Operating Income | $-226.91MM | $-248.03MM | $-207.78MM |
| Non-Operating Income | $0.12MM | $6.71MM | $9.14MM |
| R&D Expense | $182.89MM | $179.21MM | $158.66MM |
| Income(Loss) | $-226.79MM | $-241.32MM | $-198.64MM |
| Taxes | $0.00MM | $-6.71MM | $0.00MM |
| Profit(Loss) | $-226.79MM | $-234.60MM | $-198.64MM |
| Stockholders Equity | $558.02MM | $355.97MM | $177.47MM |
| Inventory | $0.23MM | $0.38MM | $0.00MM |
| Assets | $620.09MM | $383.17MM | $229.18MM |
| Operating Cash Flow | $-184.74MM | $-219.99MM | $-173.16MM |
| Capital expenditure | $0.08MM | $1.71MM | $0.61MM |
| Investing Cash Flow | $-50.71MM | $-230.67MM | $280.68MM |
| Financing Cash Flow | $662.68MM | $0.51MM | $1.04MM |
| Earnings Per Share* | $-2.11 | $-2.17 | $-1.81 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.